ACE2 and COVID-19: In a study including hospitalized patients with COVID-19 age, high soluble ACE2 levels, a low aldosterone to renin ratio and the TMPRSS2 rs2070788 non-AA genotype were factors that independently predicted disease severity (Akin et al., 2021).